Financials & Filings

Financials & Filings

SEC Filings

Filing date	Form	Description	Filing Group	View
May 13, 2021	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	View HTML 0001213900-21-025892.pdf 0001213900-21-025892.rtf 0001213900-21-025892.xls EX-101.INS - XBRL INSTANCE FILE
May 13, 2021	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001213900-21-026106.pdf 0001213900-21-026106.rtf 0001213900-21-026106.xls
May 06, 2021	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001213900-21-024778.pdf 0001213900-21-024778.rtf 0001213900-21-024778.xls
May 04, 2021	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001213900-21-024429.pdf 0001213900-21-024429.rtf 0001213900-21-024429.xls
Apr 28, 2021	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001213900-21-023215.pdf 0001213900-21-023215.rtf 0001213900-21-023215.xls
Apr 28, 2021	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001213900-21-023230.pdf 0001213900-21-023230.rtf 0001213900-21-023230.xls
Apr 27, 2021	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001213900-21-023087.pdf 0001213900-21-023087.rtf 0001213900-21-023087.xls
Mar 16, 2021	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	Registration Statements	View HTML 0001213900-21-015491.pdf 0001213900-21-015491.rtf 0001213900-21-015491.xls
Mar 15, 2021	EFFECT	EFFECT	Other	View HTML 9999999995-21-000952.pdf 9999999995-21-000952.rtf 9999999995-21-000952.xls
Mar 05, 2021	S-8	Securities offered to employees pursuant to employee benefit plans	Registration Statements	View HTML 0001213900-21-013661.pdf 0001213900-21-013661.rtf 0001213900-21-013661.xls

Data provided by Kaleidoscope.

SEDAR Filing

SEDAR, or the System for Electronic Document Analysis and Retrieval, is a repository of regulatory documents that includes InMed Pharmaceuticals Inc. public filings with the Canadian securities regulatory authorities. To access these documents, visit the SEDAR website.

Investor Alerts

Sign up for investor alerts!

Information Request

Send us a request for information